Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
NETSTARS, 60% Increase in Ordinary Profit, Update Record High for Second Consecutive Term
5590 NETSTARS Co.,Ltd. 【J-GAAP】
Earnings ReportNETSTARS Co.,Ltd. <5590> [TSE Growth] announced its financial results after the market closed on February 12th (15:30). The consolidated ordinary profit/loss for the fiscal year ended December 2025 turned into a profit of 443 million yen (compared to a loss of 22 million yen in the previous period). For the fiscal year ending December 2026, the consolidated ordinary profit is expected to expanded to 59.6% to 707 million yen, marking the second consecutive term of record-high profits.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit grew 18.1% from the same period last year, reaching 137 million yen. However, the operating profit margin decreased from 10.6% in the same period last year to 8.0%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 3,720 | -321 | -329 | -347 | -21.5 | 0 | Feb 14, 2024 | J-GAAP |
| Dec, 2024 | 3,902 | -84 | -22 | -37 | -2.3 | 0 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 | 4,788 | 293 | 443 | 485 | 29.0 | 0 | Feb 12, 2026 | J-GAAP |
| YoY | +22.7% | - | - | - | - |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2025 Guidance | 4,850 | 233 | 390 | 276 | 16.4 | 0 | Nov 11, 2025 | J-GAAP |
| Dec, 2025 Results | 4,788 | 293 | 443 | 485 | 29.0 | 0 | Feb 12, 2026 | J-GAAP |
| Revision Rate | -1.3% | +25.8% | +13.6% | +75.7% | +76.8% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 2,158 | 59 | 151 | 127 | 7.7 | 0 | Aug 14, 2025 | J-GAAP |
| Jan - Jun, 2026 Guidance | ー | ー | ー | ー | - | 0 | Feb 12, 2026 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2024 | 3,902 | -84 | -22 | -37 | -2.3 | 0 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 | 4,788 | 293 | 443 | 485 | 29.0 | 0 | Feb 12, 2026 | J-GAAP |
| Dec, 2026 Guidance | 5,760 | 500 | 707 | 493 | 29.3 | 0 | Feb 12, 2026 | J-GAAP |
| YoY | +20.3% | +70.6% | +59.6% | +1.6% | +1.0% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 1,179 | 125 | 116 | 114 | 6.9 | 10.6 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 1,051 | -2 | 52 | 45 | 2.7 | -0.2 | May 15, 2025 | J-GAAP |
| Apr - Jun, 2025 | 1,107 | 61 | 99 | 82 | 4.9 | 5.5 | Aug 14, 2025 | J-GAAP |
| Jul - Sep, 2025 | 1,209 | 121 | 155 | 92 | 5.5 | 10.0 | Nov 13, 2025 | J-GAAP |
| Oct - Dec, 2025 | 1,421 | 113 | 137 | 266 | 15.9 | 8.0 | Feb 12, 2026 | J-GAAP |
| YoY | +20.5% | -9.6% | +18.1% | +133.3% | +129.4% |
Related Articles
Monex Group, Apr-Dec (Cumulative 3Q) Net Income Turns to Profit, Oct-Dec Net Income Turns to Profit
ROHTO PHARMA, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 6%, Exceeded Record Profit Forecast, Dividend Revised Upward by 1 Yen
CRI Middleware, Oct-Dec (1Q) Ordinary Profit Decreases by 74%
ExaWizards, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Increases by 237 times
Human Metabolome Tech, First Half Ordinary Profit Decreases by 50%
MEIWA INDUSTRY, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 10%, Oct-Dec Ordinary Profit Decreases by 83%
Relo Group, Apr-Dec (Cumulative 3Q) Net Income Decreases by 61%
PIOLAX, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 25%
TBK, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 30%
Shikino High-Tech, Ordinary Profit Forecast for the Fiscal Year Revised Downward to a Loss